← Insider buys
APRE

Aprea Therapeutics, Inc. · Healthcare

SVP and Chief Business Officer Gregory Alan Korbel sold $138K of Aprea Therapeutics, Inc.

Sold$137,500
$5.00Price
27,500Shares
−62%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Mon, Nov 1. Filed Wed, Nov 3, 1:34 PM ET, during the session. Not investment advice.